AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

11.850

-0.020-0.17%

Volume:151.69K

Turnover:1.80M

Market Cap:591.87M

PE:15.40

High:11.970

Open:11.750

Low:11.710

Close:11.870

Loading ...

Overview Company News Filings

3 Growth Stocks With High Insider Ownership And 25% Earnings Growth

Simply Wall St.

3 High-Growth Companies With Insider Ownership Up To 30%

Simply Wall St.

ASX Growth Companies With High Insider Ownership In January 2025

Simply Wall St.

ASX Growth Companies With Strong Insider Ownership

Simply Wall St.

Clinuvel Pharmaceuticals Sees Staged Repigmentation in Non-Segmental Vitiligo Study Following Combination Therapy

MT Newswires Live

3 ASX Growth Companies With Strong Insider Ownership

Simply Wall St.

BRIEF-Clinuvel Pharmaceuticals Signs Distribution Agreement For Scenesse With Diligens Salud SA

Clinuvel Pharmaceuticals Appoints Argentinian Distributor for Porphyria Therapy

MT Newswires Live

Clinuvel Pharmaceuticals - Distribution Agreement for Scenesse With Diligens Salud Sa

THOMSON REUTERS

Exploring 3 High Growth Tech Stocks In Australia

Simply Wall St.

ASX Growth Stocks With Strong Insider Confidence

Simply Wall St.

BRIEF-Clinuvel Pharmaceuticals Says Scenesse Validated And Accepted For Review

Clinuvel Pharmaceuticals' New Drug Submission Under Health Canada Review

MT Newswires Live

Clinuvel Pharmaceuticals - Scenesse Validated and Accepted for Review Ahead of Health Canada's Target Validation Window

THOMSON REUTERS

Exploring High Growth Tech Stocks in Australia December 2024

Simply Wall St.

ASX Market Close: Telcos leads index lower | November 20, 2024

The Market Herald

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":11.85,"timestamp":1741583520000,"preClose":11.87,"halted":0,"volume":151690,"delay":0,"changeRate":-0.001685,"change":-0.02,"floatShares":41256001,"shares":49946800,"eps":0.769445,"lyrEps":0.7151,"pbRate":2.72,"amount":1796840,"amplitude":0.021904,"volumeRatio":0.5695142249360717,"dividePrice":0.05,"prevYearClose":12.06,"fiveDayClose":12.23,"twentyDayClose":11.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41256001,"roa":"14.22%","roe":"19.59%","lyrEps":0.7151,"volumeRatio":0.5695142249360717,"shares":49946800,"dividePrice":0.05,"high":11.97,"amplitude":0.021904,"preClose":11.87,"low":11.71,"week52Low":10.89,"pbRate":"2.72","psRate":"6.50","week52High":17.652,"institutionHeld":0,"latestPrice":11.85,"committee":-0.359517,"eps":0.769445,"divideRate":0.004219,"volume":151690,"delay":0,"ttmEps":0.769445,"open":11.75,"prevYearClose":12.06,"prevWeekClose":11.87,"prevMonthClose":11.49,"prevQuarterClose":12.06,"fiveDayClose":12.23,"twentyDayClose":11.5,"sixtyDayClose":12.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"},{"date":"2024-08-29","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724889600000,"name":null,"time":"","dateTimestamp":1724853600000,"actualEps":null},{"date":"2024-02-22","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":"2023-08-29","type":"dividend","market":"AU","newRecordDate":"2023-09-06","defaultRemindTime":1693872000000,"name":"Clinuvel Pharmaceuticals Ltd","recordDate":"2023-09-20","payableDate":"2023-09-06","currency":"AUD","dateTimestamp":1693836000000,"payDate":"2023-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CUV.AU\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507631057","title":"3 Growth Stocks With High Insider Ownership And 25% Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631057","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507631057?lang=en_us&edition=fundamental","pubTime":"2025-01-29 15:01","pubTimestamp":1738134100,"startTime":"0","endTime":"0","summary":"As global markets continue to react positively to recent political developments and growing enthusiasm for artificial intelligence, major indices like the S&P 500 have reached new record highs. In this environment, growth stocks with high insider ownership and impressive earnings growth stand out as potentially strong performers, offering a unique combination of internal confidence and financial momentum.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4313000-choice2-main-header/1585186808281","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4313000-choice2-main-header/1585186808281"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/jp/media/tse-3791/ig-port-shares/news/3-growth-stocks-with-high-insider-ownership-and-25-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","FND.AU","SKS.AU","CUV.AU","BK7158","BK7043","PLT.AU","BK7023","BK7093"],"gpt_icon":0},{"id":"2506379159","title":"3 High-Growth Companies With Insider Ownership Up To 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506379159","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506379159?lang=en_us&edition=fundamental","pubTime":"2025-01-27 18:01","pubTimestamp":1737972105,"startTime":"0","endTime":"0","summary":"As global markets continue to respond positively to political developments and economic indicators, with U.S. stocks reaching record highs amid AI enthusiasm and potential trade deals, investors are increasingly focused on growth opportunities. In this context, companies with high insider ownership can be particularly attractive as they often signal strong internal confidence in the business's future prospects, aligning management interests closely with those of shareholders.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3112400-choice2-main-header/1585186895258","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112400-choice2-main-header/1585186895258"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-services/hkg-2469/fenbi-shares/news/3-high-growth-companies-with-insider-ownership-up-to-30","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7158","BK1593","BK7104","BK1100","BK7067","BK7506","BK7043","BK1587","BK7508","BTR.AU","06699","CUV.AU","BK1583","FND.AU"],"gpt_icon":0},{"id":"2506317246","title":"ASX Growth Companies With High Insider Ownership In January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506317246","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506317246?lang=en_us&edition=fundamental","pubTime":"2025-01-27 12:01","pubTimestamp":1737950489,"startTime":"0","endTime":"0","summary":"As the Australian market continues to navigate the economic landscape shaped by the new Trump administration, the ASX200 has shown resilience, closing up 0.36% at 8,408 points amid positive tariff developments. In this environment of cautious optimism, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business and may offer potential stability in a fluctuating market.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 89 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and other international markets with a market cap of A$591.37 million.Overview: Develop Global Limited, along wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-high-insider-040129347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XKO.AU","FND.AU","3DP.AU","BK7043","BTR.AU","CUV.AU","GYG.AU","NWF.AU","BK7116","DVP.AU","BK7104","BK7096","BK7095","SKS.AU","PLT.AU","BK7508","XJO.AU","BK7067","ACR.AU","BK7137","AVA.AU","BK7158","BK7506","MM8.AU","BK7016","BK7023","XAO.AU","BK7084","BK7093"],"gpt_icon":0},{"id":"2505763084","title":"ASX Growth Companies With Strong Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2505763084","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505763084?lang=en_us&edition=fundamental","pubTime":"2025-01-22 12:04","pubTimestamp":1737518666,"startTime":"0","endTime":"0","summary":"The Australian market has shown a modest uptick, with the ASX200 rising 0.5% to 8,445 points, as sectors like IT and Discretionary lead gains despite geopolitical tensions surrounding U.S.-China trade relations. In this environment of sector-specific growth and market fluctuations, identifying companies with strong insider ownership can be crucial for investors seeking alignment between management interests and shareholder value.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 89 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Flight Centre Travel Group is poised for growth, with earnings forecast to increase by 19% annually, surpassing the Australian market's average. Despite a slower revenue growth rate of 7.2%, it remains above the market average. Recent insider activity shows more buying than selling, suggesting confide","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-companies-strong-insider-040426649.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MM8.AU","3DP.AU","BK7503","FND.AU","C79.AU","BK7096","BK7023","BK7050","BK7070","BK7064","BK7043","BTR.AU","SKS.AU","AVA.AU","BK7506","XJO.AU","BK7508","XKO.AU","BK7067","FLT.AU","PLT.AU","XAO.AU","ACR.AU","NWF.AU","TNE.AU","CUV.AU","BK7116","BK7104","BK7093","BK7158","BK7084","BK7016"],"gpt_icon":0},{"id":"2504445570","title":"Clinuvel Pharmaceuticals Sees Staged Repigmentation in Non-Segmental Vitiligo Study Following Combination Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2504445570","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504445570?lang=en_us&edition=fundamental","pubTime":"2025-01-20 10:40","pubTimestamp":1737340852,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  said its CUV105 study showed staged repigmentation in non-segmental vitiligo patients following a combination treatment with its photoprotective drug Scensse  and narrowband ultraviolet B  therapy, according to a Monday filing with the Australian bourse.It highlighted four case reports that provide insight into how the treatment aids repigmentation in vitiligo patients, particularly those with darker skin types, the filing said.After 26 weeks of treatment, Clinuvel sees that unaffected and repigmented skin returns to baseline complexion, the filing added.The results align with Clinuvel's focus on addressing the needs of patients with significant medical requirements and its commitment to advancing afamelanotide as a treatment for non-segmental vitiligo, the filing added.Clinuvel's CUV105 clinical trial is evaluating several key objectives in patients, with a key endpoint being a 50% improvement in the total vitiligo area scoring index.Shares of the company fel","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CUV.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2504090150","title":"3 ASX Growth Companies With Strong Insider Ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2504090150","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504090150?lang=en_us&edition=fundamental","pubTime":"2025-01-17 12:06","pubTimestamp":1737086761,"startTime":"0","endTime":"0","summary":"In the current Australian market landscape, the ASX200 has seen a modest increase of 0.21%, with sectors like Discretionary, Utilities, and Industrials leading the charge. In this context of sectoral strength and market resilience, identifying growth companies with strong insider ownership can be a strategic approach for investors seeking to align their interests with those who have significant stakes in their company's success.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 89 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Pinnacle Investment Management Group's growth trajectory is supported by earnings and revenue forecasts that exceed the Australian market averages, with earnings expected to grow at 16.5% annually. Recent follow-on equity offerings, totaling A$425 million, suggest strategic capital raising efforts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-companies-strong-040601213.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7021","BK7023","BK7043","BK7116","XJO.AU","BK7158","BK7051","MM8.AU","BK7093","SKS.AU","BK7049","BTR.AU","BK7096","CUV.AU","BK7104","BK7084","ACR.AU","FND.AU","BK7067","PNI.AU","PWH.AU","BK7062","NWF.AU","XAO.AU","BK7506","CTT.AU","XKO.AU","AVA.AU","BK7508","PLT.AU","EMR.AU"],"gpt_icon":0},{"id":"2504803976","title":"BRIEF-Clinuvel Pharmaceuticals Signs Distribution Agreement For Scenesse With Diligens Salud SA","url":"https://stock-news.laohu8.com/highlight/detail?id=2504803976","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504803976?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:23","pubTimestamp":1737077025,"startTime":"0","endTime":"0","summary":"BRIEF-Clinuvel Pharmaceuticals Signs Distribution Agreement For Scenesse With Diligens Salud SAJan 17 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:DISTRIBUTION AGREEMENT FOR SCENESSE WITH DILIGENS SALUD SAFurther company coverage: CUV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250117:nFWN3OC0OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","CUV.AU","BK7508"],"gpt_icon":0},{"id":"2504292760","title":"Clinuvel Pharmaceuticals Appoints Argentinian Distributor for Porphyria Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2504292760","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504292760?lang=en_us&edition=fundamental","pubTime":"2025-01-17 07:56","pubTimestamp":1737071813,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals (ASX:CUV) appointed specialty pharmaceutical firm Diligens Salud, part of the Scienza Group, to market and sell the Scenesse (afamelanotide) therapy in Argentina, according to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","CUV.AU","BK7067"],"gpt_icon":0},{"id":"2504772926","title":"Clinuvel Pharmaceuticals -  Distribution Agreement for Scenesse With Diligens Salud Sa","url":"https://stock-news.laohu8.com/highlight/detail?id=2504772926","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504772926?lang=en_us&edition=fundamental","pubTime":"2025-01-17 06:24","pubTimestamp":1737066250,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250116:nFWN3OC0OP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUV.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2500158639","title":"Exploring 3 High Growth Tech Stocks In Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2500158639","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500158639?lang=en_us&edition=fundamental","pubTime":"2025-01-03 12:07","pubTimestamp":1735877241,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a cautious start to the year, with the ASX 200 expected to open slightly lower amid global uncertainties and a weakening Aussie dollar, reflecting broader concerns about economic data and interest rate projections. In this environment, identifying high-growth tech stocks requires careful consideration of factors such as innovative potential and resilience in fluctuating market conditions.Click here to see the full list of 60 stocks from our ASX High Growth Tech and AI Stocks screener.Underneath we present a selection of stocks filtered out by our screen.Overview: Clinuvel Pharmaceuticals Limited is a biopharmaceutical company that develops and commercializes treatments for genetic, metabolic, systemic, and life-threatening disorders across Australia, Europe, the United States, Switzerland, and internationally with a market cap of A$602.36 million.Operations: Clinuvel Pharmaceuticals generates revenue primarily from its biopharmaceutical sector, amo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-3-high-growth-tech-040721425.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MESO","MSB.AU","XJO.AU","BK7067","XAO.AU","XKO.AU","FCL.AU","BK7501","BK7016","BK7508","CUV.AU"],"gpt_icon":0},{"id":"2494099951","title":"ASX Growth Stocks With Strong Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2494099951","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494099951?lang=en_us&edition=fundamental","pubTime":"2024-12-25 12:01","pubTimestamp":1735099291,"startTime":"0","endTime":"0","summary":"As the Australian stock market closes on a positive note with a modest gain in the ASX 200, investors are digesting the Reserve Bank of Australia's recent minutes that highlight persistent inflation concerns. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 95 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Accent Group shows potential as a growth company with high insider ownership. Its earnings are forecast to grow at 13.7% annually, outpacing the Australian market's growth rate of 12.5%. However, profit margins have declined from 6.2% to 4.1%. The stock is trading at a significant discount to its estimated fair value, suggesting potential undervaluation. Recent board appointments, including Dave Forsey as an Independen","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-growth-stocks-strong-insider-040131447.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XJO.AU","BK7084","BK7043","BK7116","XAO.AU","BK7067","BK7508","SKS.AU","BK7033","GYG.AU","NWF.AU","BK7093","AX1.AU","BK7021","3DP.AU","XKO.AU","BTR.AU","PLT.AU","CCA.AU","BK7016","ACR.AU","AVA.AU","IPX.AU","BK7137","FND.AU","CUV.AU","BK7096","BK7158","BK7023","BK7104","BK7506"],"gpt_icon":1},{"id":"2493272831","title":"BRIEF-Clinuvel Pharmaceuticals Says Scenesse Validated And Accepted For Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2493272831","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493272831?lang=en_us&edition=fundamental","pubTime":"2024-12-23 09:28","pubTimestamp":1734917297,"startTime":"0","endTime":"0","summary":"Dec 23 (Reuters) - Clinuvel Pharmaceuticals Ltd :   * SCENESSE VALIDATED AND ACCEPTED FOR REVIEW AHEAD OF HEALTH CANADA'S TARGET VALIDATION WINDOWSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","CUV.AU"],"gpt_icon":0},{"id":"2493279189","title":"Clinuvel Pharmaceuticals' New Drug Submission Under Health Canada Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2493279189","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493279189?lang=en_us&edition=fundamental","pubTime":"2024-12-23 08:40","pubTimestamp":1734914404,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals  said its new drug submission to Health Canada for its photoprotective therapy Scenesse was validated and accepted for review ahead of the regulator's target validation window, according to a Monday filing with the Australian bourse.Scenesse was designed to prevent phototoxicity in adult patients with erythropoietic protoporphyria an inherited metabolic disorder.The submission is now under review by Health Canada's Health Products and Food Branch, which has a 300-day target to complete its evaluation and issue a marketing authorization decision, the filing said. A decision is expected by the fourth quarter of 2025.Clinuvel Pharmaceuticals shares rose nearly 1% in morning trade Monday.Price : $11.90, Change: $+0.11, Percent Change: +0.93%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","AUD","LU0345774631.USD","BK7508","CUV.AU","BK4125","LU0426417589.USD","LU1043141123.HKD","LU0994945656.USD","LU0426412945.USD","LU2238339852.HKD"],"gpt_icon":0},{"id":"2493208602","title":"Clinuvel Pharmaceuticals - Scenesse Validated and Accepted for Review Ahead of Health Canada's Target Validation Window","url":"https://stock-news.laohu8.com/highlight/detail?id=2493208602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493208602?lang=en_us&edition=fundamental","pubTime":"2024-12-23 06:17","pubTimestamp":1734905839,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241222:nFWN3NL1KI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CUV.AU","BK7067","BK7508"],"gpt_icon":0},{"id":"2489592109","title":"Exploring High Growth Tech Stocks in Australia December 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2489592109","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489592109?lang=en_us&edition=fundamental","pubTime":"2024-12-05 12:07","pubTimestamp":1733371641,"startTime":"0","endTime":"0","summary":"As the Australian market experiences a modest uptick with the ASX200 rising by 0.3% to 8,488 points, the IT sector stands out as a strong performer, climbing by 1.1%, amidst broader economic indicators suggesting potential volatility and constraints in the coming year. In this environment, identifying high-growth tech stocks requires careful consideration of their ability to thrive in dynamic conditions and leverage technological advancements to sustain momentum within an evolving market landscape.Click here to see the full list of 58 stocks from our ASX High Growth Tech and AI Stocks screener.Overview: FINEOS Corporation Holdings plc develops and sells enterprise claims and policy management software for the employee benefits and life, accident, and health insurance industries globally, with a market capitalization of A$652.96 million.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exploring-high-growth-tech-stocks-040721351.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XKO.AU","CUV.AU","BK7508","XJO.AU","BK7067","XAO.AU","BK7501","MESO","MSB.AU","BK7016","FCL.AU"],"gpt_icon":0},{"id":"2484050159","title":"ASX Market Close: Telcos leads index lower | November 20, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2484050159","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484050159?lang=en_us&edition=fundamental","pubTime":"2024-11-20 14:19","pubTimestamp":1732083540,"startTime":"0","endTime":"0","summary":"The ASX 200 closed down 0.57% at 8,326 points.Total wages and salaries paid by employers in Australia reached a record high of $103.7 billion in September, marking a 3.9% increase of $3.9 billion from the previous month, according to the Australian Bureau of Statistics.The Telecommunication sector was the biggest loser, down 1.5%, followed by Industrials, down 1.3% and Discretionary, down 1.1%.Health Care was best performer, gaining 0.25%, followed by Utilities, up 0.2%.Sparc Technologies  closed up 2.94% on news its teaming up withSantos to trial its anti-corrosion coating on assets in South Australia.Greenvale Energyclosed up 3.45% on news it will be expanding its uranium exploration portfolio with the acquisition of the Elkedra Uranium Project in the Northern Territory. The project is located 300km northeast of Alice Springs and 200km southeast of Tennant Creek, within the geologically significant Cambrian Georgina Basin.Webjet  closed down 9.78% after the online travel agent warned","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-telcos-leads-index-lower-november-20-2024-2024-11-20/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["WJL.AU","CUV.AU","GRE.AU","XKO.AU","STO.AU","XJO.AU","BK7508","BK7036","BK7093","BK7507","PLT.AU","SPN.AU","XAO.AU","BK7067","BK7142","BK7070","BK7095","GRV.AU"],"gpt_icon":0}],"pageSize":16,"totalPage":5,"pageCount":2,"totalSize":66}]}}